| |
Latest 10 SEC filings (by transaction date) for TLRY within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 19/24 | Jan 19/24 | Persofsky Renah | Direct Ownership | Restricted Stock Units | D - Disposition to issuer under Rule 16b-3(e) | -129,534 | |
Jan 18/24 | Jan 17/24 | Faltischek Denise M | Direct Ownership | Common Stock | P - Open market or private purchase | 10,000 | $2.05 |
Jan 16/24 | Jan 16/24 | Gendel Mitchell | Direct Ownership | Common Stock | P - Open market or private purchase | 7,200 | $1.98 |
Jan 12/24 | Jan 12/24 | Gendel Mitchell | Direct Ownership | Common Stock | P - Open market or private purchase | 5,400 | $1.87 |
Jan 12/24 | Jan 12/24 | Simon Irwin D | Direct Ownership | Common Stock | P - Open market or private purchase | 53,700 | $1.88 |
Jan 12/24 | Jan 12/24 | Merton Carl A | Indirect Ownership | Common Stock | P - Open market or private purchase | 20,000 | $1.87 |
Aug 2/23 | Jul 31/23 | Merton Carl A | Direct Ownership | Performance-Based Restricted Stock Units ("2022 PSUs") | M - Exercise or conversion exempt under rule 16b-3 | -93,926 | |
Aug 2/23 | Jul 31/23 | Merton Carl A | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -94,227 | $2.53 |
Aug 2/23 | Jul 31/23 | Merton Carl A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 187,852 | $2.53 |
Aug 2/23 | Jul 31/23 | Simon Irwin D | Direct Ownership | Performance-Based Restricted Stock Units ("2022 PSUs") | M - Exercise or conversion exempt under rule 16b-3 | -706,214 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for TLRY within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 19/24 | Jan 19/24 | Persofsky Renah | Direct Ownership | Restricted Stock Units | D - Disposition to issuer under Rule 16b-3(e) | -129,534 | |
Jan 18/24 | Jan 17/24 | Faltischek Denise M | Direct Ownership | Common Stock | P - Open market or private purchase | 10,000 | $2.05 |
Jan 16/24 | Jan 16/24 | Gendel Mitchell | Direct Ownership | Common Stock | P - Open market or private purchase | 7,200 | $1.98 |
Jan 12/24 | Jan 12/24 | Gendel Mitchell | Direct Ownership | Common Stock | P - Open market or private purchase | 5,400 | $1.87 |
Jan 12/24 | Jan 12/24 | Simon Irwin D | Direct Ownership | Common Stock | P - Open market or private purchase | 53,700 | $1.88 |
Jan 12/24 | Jan 12/24 | Merton Carl A | Indirect Ownership | Common Stock | P - Open market or private purchase | 20,000 | $1.87 |
Aug 2/23 | Jul 31/23 | Merton Carl A | Direct Ownership | Performance-Based Restricted Stock Units ("2022 PSUs") | M - Exercise or conversion exempt under rule 16b-3 | -93,926 | |
Aug 2/23 | Jul 31/23 | Merton Carl A | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -94,227 | $2.53 |
Aug 2/23 | Jul 31/23 | Merton Carl A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 187,852 | $2.53 |
Aug 2/23 | Jul 31/23 | Simon Irwin D | Direct Ownership | Performance-Based Restricted Stock Units ("2022 PSUs") | M - Exercise or conversion exempt under rule 16b-3 | -706,214 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |